甲流H1N1精品课件Influenza A（H1N1） （Swine Flu） .pptVIP

For additional information, please see: Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition Section IV Laboratory Biosafety Level Criteria (/OD/ohs/biosfty/bmbl5/bmbl5toc.htm) FDA authorizes emergency use of influenza medicines, diagnostic test in response to swine flu outbreak in humans [news release]. Rockville, MD: U.S. Food and Drug Administration. April 27, 2009. /bbs/topics/NEWS/2009/NEW02002.html. Accessed April 28, 2009. HHS declares public health emergency for swine flu [news release]. Washington, DC: U.S. Department of Health and Human Services. April 26, 2009. /news/press/2009pres/04.html. Accessed April 27, 2009. For more information about Reye’s syndrome, visit the National Institute of Health website at /disorders/reyes_syndrome/reyes_syndrome.htm For information on homecare visit: /swineflu/guidance_homecare.htm Pregnant Women Oseltamivir and zanamivir are Pregnancy Category C medications, indicating that no clinical studies have been conducted to assess the safety of these medications for pregnant women. Because of the unknown effects of influenza antiviral drugs on pregnant women and their fetuses, oseltamivir or zanamivir should be used during pregnancy only if the potential benefit justifies the potential risk to the embryo or fetus; the manufacturers package inserts should be consulted. However, no adverse effects have been reported among women who received oseltamivir or zanamivir during pregnancy or among infants born to women who have received oseltamivir or zanamivir. Pregnancy should not be considered a contraindication to oseltamivir or zanamivir use. Because of its systemic activity, oseltamivir is preferred for treatment of pregnant women.? The drug of choice for prophylaxis is less clear.? Zanamivir may be preferable because of its limited systemic absorption; however, respiratory complications that may be associated with zanamivir because of its inhaled route of administration need to be considered,